A population pharmacokinetic model is beneficial in quantifying hair concentrations of ritonavir-boosted atazanavir: a study of HIV-infected Zimbabwean adolescents
Abstract Background Adolescents experience higher levels of non-adherence to HIV treatment. Drug concentration in hair promises to be reliable for assessing exposure to antiretroviral (ARV) drugs. Pharmacokinetic modelling can explore utility of drug in hair. We aimed at developing and validating a...
Saved in:
Main Authors: | Bernard Ngara (Author), Simbarashe Zvada (Author), Tariro Dianah Chawana (Author), Babill Stray-Pedersen (Author), Charles Fungai Brian Nhachi (Author), Simbarashe Rusakaniko (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetic-pharmacodynamic modelling of atazanavir in hair among adolescents on antiretroviral treatment in Zimbabwe
by: Bernard Ngara, et al.
Published: (2021) -
The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth
by: Mashavave Grace V, et al.
Published: (2010) -
Physiologically based pharmacokinetic modeling of drug-drug interactions between ritonavir‐boosted atazanavir and rifampicin in pregnancy
by: Shakir Atoyebi, et al.
Published: (2024) -
A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study
by: Spagnuolo V, et al.
Published: (2019) -
Comparison of non-invasive methods of assessing liver fibrosis in combination ART-experienced Zimbabweans
by: Brenda Nherera, et al.
Published: (2019)